000 | 01776 a2200565 4500 | ||
---|---|---|---|
005 | 20250515005321.0 | ||
264 | 0 | _c20051213 | |
008 | 200512s 0 0 eng d | ||
022 | _a0022-3050 | ||
024 | 7 |
_a10.1136/jnnp.2005.063206 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchüpbach, W M M | |
245 | 0 | 0 |
_aStimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. _h[electronic resource] |
260 |
_bJournal of neurology, neurosurgery, and psychiatry _cDec 2005 |
||
300 |
_a1640-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aActivities of Daily Living |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntiparkinson Agents _xtherapeutic use |
650 | 0 | 4 |
_aCognition Disorders _xetiology |
650 | 0 | 4 | _aDeep Brain Stimulation |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLevodopa _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMotor Skills Disorders |
650 | 0 | 4 |
_aParkinson Disease _xtherapy |
650 | 0 | 4 | _aSubthalamic Nucleus |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aChastan, N | |
700 | 1 | _aWelter, M L | |
700 | 1 | _aHoueto, J L | |
700 | 1 | _aMesnage, V | |
700 | 1 | _aBonnet, A M | |
700 | 1 | _aCzernecki, V | |
700 | 1 | _aMaltête, D | |
700 | 1 | _aHartmann, A | |
700 | 1 | _aMallet, L | |
700 | 1 | _aPidoux, B | |
700 | 1 | _aDormont, D | |
700 | 1 | _aNavarro, S | |
700 | 1 | _aCornu, P | |
700 | 1 | _aMallet, A | |
700 | 1 | _aAgid, Y | |
773 | 0 |
_tJournal of neurology, neurosurgery, and psychiatry _gvol. 76 _gno. 12 _gp. 1640-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/jnnp.2005.063206 _zAvailable from publisher's website |
999 |
_c15916003 _d15916003 |